Abbott Expands Commitment To Vascular Device Biz Through Biocompatibles
This article was originally published in The Gray Sheet
Executive Summary
Abbott's acquisition of Biocompatibles' stent business, unveiled March 18, reflects an expanded commitment by Abbott to its vascular medicine franchise - particularly focusing on high growth market segments like stents, vessel closure and embolic protection